Physician profile
Beverly L Philson
NPI 1063651982
$5,643.06
in general payments reported to CMS, 2019-2025
9 companies · $1,565 in 2025
The $1,565 reported for 2025 was more than what 86% of Psychiatric/Mental Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $244).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $727 · 2022: $810 · 2023: $1,148 · 2024: $1,393 · 2025: $1,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,106.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $1,451.56 | 2021-2025 | Ingrezza |
| Janssen Pharmaceuticals, INC | $1,270.73 | 2022-2025 | Invega Sustenna, Invega Trinza |
| Otsuka America Pharmaceutical, INC. | $921.59 | 2021-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Alkermes, INC. | $805.98 | 2021-2024 | Lybalvi, Aristada, Aristada Initio |
| Lundbeck LLC | $592.82 | 2021-2025 | Abilify Maintena, Abilify Asimtufii |
| Teva Pharmaceuticals USA, INC. | $387.66 | 2024-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Axsome Therapeutics, INC. | $143.75 | 2025 | Auvelity |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $50.34 | 2024 | Abilify Maintena |
| Solventum Corporation | $18.63 | 2025 | Filtek, Clarity Aligners, 3m Scotchbond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Philson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.